Current state of myocardial tissue engineering.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Chinese Medical Journal

• Publication date

  2009-08-05

• Fields of study

  Medicine, Engineering

• Identifiers
  PMID 19781331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac Myocyte Progenitors from Adult Hearts for Myocardial Regenerative Therapy

  2008cited by this paper
• A novel cell delivery system using magnetically labeled mesenchymal stem cells and an external magnetic device for clinical cartilage repair.

  2008cited by this paper
• Long-Term Survival and Growth of Pulsatile Myocardial Tissue Grafts Engineered by the Layering of Cardiomyocyte Sheets

  2006cited by this paper
• Mesenchymal stem cells and organ transplantation: current status and promising future.

  2006cited by this paper
• Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

  2006cited by this paper
• Immune modulation by mesenchymal stem cells.

  2006cited by this paper
• Review. Hyaluronan: A Powerful Tissue Engineering Tool

  2006cited by this paper
• Autologous Human Tissue-Engineered Heart Valves: Prospects for Systemic Application

  2006cited by this paper
• Living Autologous Heart Valves Engineered From Human Prenatally Harvested Progenitors

  2006cited by this paper
• Heart muscle engineering: an update on cardiac muscle replacement therapy.

  2006cited by this paper
• Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function.

  2005cited by this paper
• Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers.

  2005cited by this paper
• They are not stealthy in the heart: embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte-based host immune response.

  2005cited by this paper
• Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages

  2005cited by this paper
• Patient-specific embryonic stem cells derived from human SCNT blastocysts.

  2005cited by this paper
• Worldwide clinical experience with the CorCap Cardiac Support Device.

  2004cited by this paper
• Tumor cells escape suicide gene therapy by genetic and epigenetic instability.

  2004cited by this paper
• Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds

  2004cited by this paper
• Electromechanical integration of cardiomyocytes derived from human embryonic stem cells

  2004cited by this paper
• Mesenchymal stem cells and their potential as cardiac therapeutics.

  2004cited by this paper
• Evidence of a Pluripotent Human Embryonic Stem Cell Line Derived from a Cloned Blastocyst

  2004cited by this paper
• Fibrin Glue Alone and Skeletal Myoblasts in a Fibrin Scaffold Preserve Cardiac Function after Myocardial Infarction

  2004cited by this paper
• Derivation of Oocytes from Mouse Embryonic Stem Cells

  2003cited by this paper
• Organ printing: computer-aided jet-based 3D tissue engineering.

  2003cited by this paper
• Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix.

  2003cited by this paper
• Transdifferentiation of Blood-Derived Human Adult Endothelial Progenitor Cells Into Functionally Active Cardiomyocytes

  2003cited by this paper
• Adult cardiac stem cells are multipotent and support myocardial regeneration.

  2003cited by this paper
• Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity.

  2003cited by this paper
• Safety issues in cell-based intervention trials.

  2003cited by this paper
• Host-Dependent Tumorigenesis of Embryonic Stem Cell Transplantation in Experimental Stroke

  2003cited by this paper
• Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction

  2003cited by this paper
• Clinical applications of tissue engineered constructs.

  2003cited by this paper
• Effects of oxygen on engineered cardiac muscle.

  2002cited by this paper
• Fabrication of Pulsatile Cardiac Tissue Grafts Using a Novel 3-Dimensional Cell Sheet Manipulation Technique and Temperature-Responsive Cell Culture Surfaces

  2002cited by this paper
• Murine Leukemia Induced by Retroviral Gene Marking

  2002cited by this paper
• Tissue Engineering of a Differentiated Cardiac Muscle Construct

  2002cited by this paper
• Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies

  2001cited by this paper
• Bone marrow cells regenerate infarcted myocardium

  2001cited by this paper
• Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: Implications for myocardium regeneration

  2001cited by this paper
• Bioengineered Cardiac Grafts: A New Approach to Repair the Infarcted Myocardium?

  2000cited by this paper
• Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization.

  1999cited by this paper
• Cardiomyocytes can be generated from marrow stromal cells in vitro.

  1999cited by this paper
• Isolation of Putative Progenitor Endothelial Cells for Angiogenesis

  1997cited by this paper
• Three‐dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system

  1997cited by this paper
• Structural basis of end-stage failure in ischemic cardiomyopathy in humans.

  1994cited by this paper
• Tissue engineering.

  1993cited by this paper
• Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers.

  1991cited by this paper
• The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium.

  1985cited by this paper
• Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro.

  1975cited by this paper

• Biomimetic materials and scaffolds for myocardial tissue regeneration.

  2013cites this paper
• Myogenic differentiation of mesenchymal stem cells for muscle regeneration in urinary tract.

  2013cites this paper
• Electrophysiological characteristics of cardiomyocyte‐like cells from rat bone marrow derived mesenchymal stem cells by four inductors

  2013cites this paper
• Cardiac differentiation and electrophysiology characteristics of bone marrow mesenchymal stem cells.

  2012cites this paper
• RETRACTED ARTICLE New cell therapies in cardiology

  2012cites this paper
• A novel bioreactor to simulate urinary bladder mechanical properties and compliance for bladder functional tissue engineering.

  2011cites this paper